Results 71 to 80 of about 152,878 (197)

Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma

open access: yes, 2020
Asthma is a heterogeneous disease that in children is often allergen-driven with a type 2 inflammation. Sublingual immunotherapy represents an important progress in the use of personalized medicine in children with allergic asthma.
Caffarelli, Carlo   +7 more
core   +1 more source

Studies investigating peripherial blood derived cells that express the high affinity receptor for immunoglobulin E (FceRI) in allergic disorders

open access: yes, 2008
It is just forty years since the identification of immunoglobulin E (IgE) as the reagin responsible for allergen induced immediate hypersensitivity reactions.
Sihra, Bhupinder Singh
core   +1 more source

The current state of food allergy therapeutics

open access: yesHuman Vaccines & Immunotherapeutics, 2017
The prevalence of IgE mediated food allergy is an increasing public health concern. The current standard of treatment is strict avoidance of the offending food(s). There are no FDA approved treatments for food allergy.
Meng Chen, Michael Land
doaj   +1 more source

New modalities of allergen immunotherapy

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and ...
Manish Ramesh, Merhunisa Karagic
doaj   +1 more source

Stability evaluation of house dust mite vaccines for sublingual immunotherapy [PDF]

open access: yesJournal of the Serbian Chemical Society, 2010
Allergen-specific immunotherapy with house dust mite (HDM) allergen extracts can effectively alleviate the symptoms of allergic rhinitis and asthma. The efficacy of the immunotherapeutic treatment is highly dependent on the quality of house dust mite ...
MARIJA GAVROVIĆ-JANKULOVIĆ   +3 more
doaj  

Current Insights into Immunotherapy Approaches for Food Allergy

open access: yesImmunoTargets and Therapy, 2021
Jessica D Macdougall,1 A Wesley Burks,1 Edwin H Kim2 1Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA; 2Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC ...
Macdougall JD, Burks AW, Kim EH
doaj  

Future developments in sublingual immunotherapy [PDF]

open access: yesAllergy, 2006
The increasing prevalence of allergic rhinitis and its progression to asthma has severe implications for patients and health care systems in many countries. An ideal therapy is one that is effective not only against symptoms but also towards the natural progression of the allergic disease.
openaire   +2 more sources

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center

open access: yes, 2017
Marie-Luise Lemberg,1 Till Berk,2 Kija Shah-Hosseini,1 Elena-Manja Kasche,1,3 Ralph Mösges1 1Faculty of Medicine, Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany; 2Department of Trauma Surgery,
Mösges R   +4 more
core  

Low dose of sublingual immunotherapy in patients with allergic rhinitis in a randomized double-blind placebocontrolled study [PDF]

open access: yes, 2010
Background: Few placebo controlled studies for sublingual immunotherapy (SLIT) have been performed so far in Latin America, and some issues like treatment scheme and doses remain uncertain Objective: to asses improvement in nasal, pharyngeal and ocular ...
Cárdenas Estrada, Eloy   +6 more
core   +1 more source

Debut of Gastroesophageal Reflux Concomitant with Administration of Sublingual Immunotherapy

open access: yesCase Reports in Gastrointestinal Medicine, 2017
Gastroesophageal reflux disease (GORD) is an often debilitating condition characterised by retrograde flow of content from stomach into the oesophagus, where the low pH of the stomach acid irritates the mucosa of the oesophagus.
Jacob Juel
doaj   +1 more source

Home - About - Disclaimer - Privacy